Other delivery systems for anti-PLK1 siRNA to be utilized specifically in BC cell lineages have been recently tested using a 50 nm mesoporous silica nanoparticle (MSNP) core coated with bioreducible cross-linked PEI and PEG polymers [313]. Here, PLK1 is linked to breast cancer.